Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine
Limited safety data are available on inadvertent exposure to quadrivalent human papillomavirus vaccine (4vHPV) during pregnancy. We conducted a descriptive observational postlicensure safety surveillance study in Kaiser Permanente Southern California and Northern California to assess congenital anom...
Main Authors: | Lina S. Sy, Kristin I. Meyer, Nicola P. Klein, Chun Chao, Christine Velicer, T. Craig Cheetham, Bradley K. Ackerson, Jeff M. Slezak, Harpreet S. Takhar, John Hansen, Kamala Deosaransingh, Kai-Li Liaw, Steven J. Jacobsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-02-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1403702 |
Similar Items
-
Characteristics of Phase IV Clinical Trials in Oncology: An Analysis Using the ClinicalTrials.gov Registry Data
by: Brandon Michael Henry, et al.
Published: (2023-06-01) -
Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01) -
Analysis of the decisions of foreign regulatory authorities
by: Relevant information
Published: (2019-06-01) -
Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01) -
Monitoring of Foreign Drug Safety Information
by: Editorial article
Published: (2019-12-01)